Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps.

“I went to a clinic a few times and they pretty much said it was a sinus infection.” After Hunter became too weak to walk to classes, she underwent a blood test. When doctors received the ...

Asthma and Antibiotic Use May Predict Nasal Polyp Recurrence After Endoscopic Sinus Surgery Feb. 4, 2025 — The probability of revision sinus surgery including the removal of nasal polyps is ...

Different RTIs were analysed separately, and this paper focuses on patients with acute sinusitis. Methods, design and patients: This was an open-label, prospective, uncontrolled, post-marketing ...

Representatives from a major national laboratory are on island, talking to local officials about the potential for a facility that could produce energy using the temperature difference in Guam’s ...

Additionally, people with allergies and nasal polyps (growths) in the nasal and facial cavities are at greater risk of developing a sinus infection. Harvard Health Publishing Harvard Medical School.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Cayman’s utilities regulator has approved a proposal by power firm CUC to add more generation capacity in a bid to avoid blackouts — but with fossil fuels rather than green energy. Officials ...